<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>WGA InsureBlog &#187; drug and safety</title>
	<atom:link href="http://blog.wgains.com/tag/drug-and-safety/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.wgains.com</link>
	<description></description>
	<lastBuildDate>Fri, 03 Feb 2012 18:21:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='blog.wgains.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>WGA InsureBlog &#187; drug and safety</title>
		<link>http://blog.wgains.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://blog.wgains.com/osd.xml" title="WGA InsureBlog" />
	<atom:link rel='hub' href='http://blog.wgains.com/?pushpress=hub'/>
		<item>
		<title>Drug rationing discussed in New England Journal of Medicine</title>
		<link>http://blog.wgains.com/2010/09/23/drug-rationing-discussed-in-new-england-journal-of-medicine/</link>
		<comments>http://blog.wgains.com/2010/09/23/drug-rationing-discussed-in-new-england-journal-of-medicine/#comments</comments>
		<pubDate>Thu, 23 Sep 2010 14:56:20 +0000</pubDate>
		<dc:creator>Phil Edmundson</dc:creator>
				<category><![CDATA[Property & Casualty]]></category>
		<category><![CDATA[drug and safety]]></category>
		<category><![CDATA[life sciences]]></category>

		<guid isPermaLink="false">http://blog.wgains.com/?p=1399</guid>
		<description><![CDATA[A report in the New York Times reviewed a position in the New England Journal of Medicine it called &#8220;unusual&#8221; &#8211; arguing two sides of a medical point in one issue. The study in question was about a new blood thinning medicine which was proven to be effective but at significant cost. It would make [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=blog.wgains.com&amp;blog=9867145&amp;post=1399&amp;subd=wgains&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://blog.wgains.com/2010/09/23/drug-rationing-discussed-in-new-england-journal-of-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Phil Edmundson</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/09/blood.png" medium="image">
			<media:title type="html">blood</media:title>
		</media:content>

		<media:content url="http://www.wgains.com/assets/blog/philedmundson_03.png" medium="image">
			<media:title type="html">Phil Edmundson</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/share_03.png" medium="image">
			<media:title type="html">Share</media:title>
		</media:content>
	</item>
		<item>
		<title>Allergan pleads guilty and agrees to pay $600 million to settle charges that it marketed Botox for off-label uses</title>
		<link>http://blog.wgains.com/2010/09/09/allergan-pleads-guilty-and-agrees-to-pay-600-million-to-settle-charges-that-it-marketed-botox-for-off-label-uses/</link>
		<comments>http://blog.wgains.com/2010/09/09/allergan-pleads-guilty-and-agrees-to-pay-600-million-to-settle-charges-that-it-marketed-botox-for-off-label-uses/#comments</comments>
		<pubDate>Thu, 09 Sep 2010 19:15:08 +0000</pubDate>
		<dc:creator>Michael Kearney</dc:creator>
				<category><![CDATA[Property & Casualty]]></category>
		<category><![CDATA[drug and safety]]></category>
		<category><![CDATA[FDA regulations]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[off-label use]]></category>

		<guid isPermaLink="false">http://blog.wgains.com/?p=1373</guid>
		<description><![CDATA[According to the Department of Justice, Allergan made it a “top corporate priority” to maximize sales of Botox for off-label uses by employing illegal marketing tactics. Those tactics included 1) calling on providers who typically treated patients with Botox for off-label conditions, 2) conducting workshops on how to bill for off-label uses of Botox and [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=blog.wgains.com&amp;blog=9867145&amp;post=1373&amp;subd=wgains&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://blog.wgains.com/2010/09/09/allergan-pleads-guilty-and-agrees-to-pay-600-million-to-settle-charges-that-it-marketed-botox-for-off-label-uses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">mkearney5150</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/09/botox.png?w=150" medium="image">
			<media:title type="html">botox</media:title>
		</media:content>

		<media:content url="http://www.wgains.com/assets/blog/michaelkearney.png" medium="image">
			<media:title type="html">MikeKearney</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/share_03.png" medium="image">
			<media:title type="html">Share</media:title>
		</media:content>
	</item>
		<item>
		<title>Product withdrawal opens drug companies to litigation</title>
		<link>http://blog.wgains.com/2010/04/16/product-withdrawal-opens-drug-companies-to-litigation/</link>
		<comments>http://blog.wgains.com/2010/04/16/product-withdrawal-opens-drug-companies-to-litigation/#comments</comments>
		<pubDate>Fri, 16 Apr 2010 18:01:29 +0000</pubDate>
		<dc:creator>Phil Edmundson</dc:creator>
				<category><![CDATA[Property & Casualty]]></category>
		<category><![CDATA[drug and safety]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[reputational injury]]></category>
		<category><![CDATA[single source supplier]]></category>
		<category><![CDATA[supply chain risks]]></category>

		<guid isPermaLink="false">http://blog.wgains.com/?p=848</guid>
		<description><![CDATA[Yesterday&#8217;s New York Times describes possible harm to customers of biotechnology giant, Genzyme Corporation, arising out of the reduced availability of Genzyme&#8217;s products as a result of a plant shutdown caused by a virus contamination at Genzyme&#8217;s plant. The story relates that such a viral contamination is not uncommon in the production of biological products. The [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=blog.wgains.com&amp;blog=9867145&amp;post=848&amp;subd=wgains&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://blog.wgains.com/2010/04/16/product-withdrawal-opens-drug-companies-to-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Phil Edmundson</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/04/genzyme.png" medium="image">
			<media:title type="html">genzyme</media:title>
		</media:content>

		<media:content url="http://www.wgains.com/assets/blog/philedmundson_03.png" medium="image">
			<media:title type="html">Phil Edmundson</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/share_03.png" medium="image">
			<media:title type="html">Share</media:title>
		</media:content>
	</item>
		<item>
		<title>New legal requirements for conducting clinical trials in Italy</title>
		<link>http://blog.wgains.com/2010/03/12/new-legal-requirements-for-conducting-clinical-trials-in-italy/</link>
		<comments>http://blog.wgains.com/2010/03/12/new-legal-requirements-for-conducting-clinical-trials-in-italy/#comments</comments>
		<pubDate>Fri, 12 Mar 2010 19:36:01 +0000</pubDate>
		<dc:creator>Amy Sinclair</dc:creator>
				<category><![CDATA[Property & Casualty]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug and safety]]></category>
		<category><![CDATA[foreign clinical trials]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[life sciences]]></category>

		<guid isPermaLink="false">http://blog.wgains.com/?p=711</guid>
		<description><![CDATA[A decree goes into effect March 14th requiring minimum insurance for any company conducting clinical trials in Italy. The new requirements were established by Italy’s Ministry of Labor, Health and Social Policy to safeguard participants in clinical trials conducted wholly or in part in that country. The requirements state that the insurance policy must cover any civil [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=blog.wgains.com&amp;blog=9867145&amp;post=711&amp;subd=wgains&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://blog.wgains.com/2010/03/12/new-legal-requirements-for-conducting-clinical-trials-in-italy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">amysinclair</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/italyblog.png?w=150" medium="image">
			<media:title type="html">italyblog</media:title>
		</media:content>

		<media:content url="http://www.wgains.com/assets/blog/amysinclair_03.png" medium="image">
			<media:title type="html">Amy Sinclair</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/share_03.png" medium="image">
			<media:title type="html">Share</media:title>
		</media:content>
	</item>
		<item>
		<title>First national drug and saftey network will help limit liability</title>
		<link>http://blog.wgains.com/2010/01/04/first-national-drug-and-saftey-network/</link>
		<comments>http://blog.wgains.com/2010/01/04/first-national-drug-and-saftey-network/#comments</comments>
		<pubDate>Tue, 05 Jan 2010 00:26:20 +0000</pubDate>
		<dc:creator>Pete Reilly</dc:creator>
				<category><![CDATA[Property & Casualty]]></category>
		<category><![CDATA[drug and safety]]></category>
		<category><![CDATA[healthcare risk management]]></category>

		<guid isPermaLink="false">http://blog.wgains.com/?p=477</guid>
		<description><![CDATA[The recent merger of the iconic Physicians’ Desk Reference (PDR®) found in every physician’s office, clinic and hospital, with the Health Care Notification Network (HCNN), the only network that delivers FDA-required drug Alerts to physicians and other prescribers online, has created a new combined service that provides FDA-required Alerts, monthly specialty-specific clinical updates and a copy of the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=blog.wgains.com&amp;blog=9867145&amp;post=477&amp;subd=wgains&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://blog.wgains.com/2010/01/04/first-national-drug-and-saftey-network/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Pete Reilly</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/01/drugs.png" medium="image">
			<media:title type="html">drugs</media:title>
		</media:content>

		<media:content url="http://www.wgains.com/assets/blog/petereilly_03.png" medium="image">
			<media:title type="html">Pete Reilly</media:title>
		</media:content>

		<media:content url="http://wgains.files.wordpress.com/2010/03/share_03.png" medium="image">
			<media:title type="html">Share</media:title>
		</media:content>
	</item>
	</channel>
</rss>
